Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
Clinical trial NCT03016325 · COMPLETED
Trial details
- NCT number
- NCT03016325
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-13
- Primary completion
- 2019-06-23
- Enrollment
- 329
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.